https://www.news18.com/news/india/popular-antacid-ranitidine-likely-to-go-off-essential-medicines-list-due-to-its-cancer-causing-concerns-5946589.html
0
0
9/13/22 at 6:23am
Organization
News18
Author
Himani Chandna
Gliptins could be added in the list as they are the latest set of medicines used to treat type 2 diabetes. The sale of Gliptins in India is valued over Rs 4,000 crore annually out of which Teneligliptin market value is at Rs 1,000 crore
Create an account
or login to join the discussion